The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
MeSH Review

Rhabdomyolysis

 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Rhabdomyolysis

 

Psychiatry related information on Rhabdomyolysis

 

High impact information on Rhabdomyolysis

 

Chemical compound and disease context of Rhabdomyolysis

 

Biological context of Rhabdomyolysis

 

Anatomical context of Rhabdomyolysis

 

Gene context of Rhabdomyolysis

 

Analytical, diagnostic and therapeutic context of Rhabdomyolysis

References

  1. Acute renal failure and rhabdomyolysis after ingestion of phenylpropanolamine-containing diet pills. Swenson, R.D., Golper, T.A., Bennett, W.M. JAMA (1982) [Pubmed]
  2. Renal failure, rhabdomyolysis, and phenylpropanolamine. Blewitt, G.A., Siegel, E.B. JAMA (1983) [Pubmed]
  3. Myositis and rhabdomyolysis associated with concurrent use of simvastatin and nefazodone. Jacobson, R.H., Wang, P., Glueck, C.J. JAMA (1997) [Pubmed]
  4. Partial muscle carnitine palmitoyltransferase-A deficiency. Rhabdomyolysis associated with transiently decreased muscle carnitine content after ibuprofen therapy. Ross, N.S., Hoppel, C.L. JAMA (1987) [Pubmed]
  5. Peripheral source of MB band of creatine kinase in alcoholic rhabdomyolysis. Nonspecificity of MB isoenzyme for myocardial injury in undiluted serum samples. Siegel, A.J., Dawson, D.M. JAMA (1980) [Pubmed]
  6. Adolescent myopathic presentation in two sisters with very long-chain acyl-CoA dehydrogenase deficiency. Merinero, B., Pascual Pascual, S.I., Pérez-Cerdá, C., Gangoiti, J., Castro, M., Garcia, M.J., Pascual Castroviejo, I., Vianey-Saban, C., Andresen, B., Gregersen, N., Ugarte, M. J. Inherit. Metab. Dis. (1999) [Pubmed]
  7. Medical complications of drug abuse. Becker, C.E. Advances in internal medicine. (1979) [Pubmed]
  8. Models of glycerol-induced acute renal failure in rats. Zurovsky, Y. Journal of basic and clinical physiology and pharmacology. (1993) [Pubmed]
  9. Dependence, dementia, cerebellar dysfunction, and myopathy in association with chronic isopropanol ingestion. Hanawalt-Squires, C., Anfinson, T.J. Psychopharmacology bulletin. (2002) [Pubmed]
  10. Encephalopathy and fatal myopathy in two siblings. Their association with partial deficiency of muscle carnitine. Parker, D., Root, A.W., Schimmel, S., Andriola, M., DiMauro, S. Am. J. Dis. Child. (1982) [Pubmed]
  11. Rhabdomyolysis from the coadministration of lovastatin and the antifungal agent itraconazole. Lees, R.S., Lees, A.M. N. Engl. J. Med. (1995) [Pubmed]
  12. Statin-associated myopathy. Thompson, P.D., Clarkson, P., Karas, R.H. JAMA (2003) [Pubmed]
  13. Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial. Serruys, P.W., de Feyter, P., Macaya, C., Kokott, N., Puel, J., Vrolix, M., Branzi, A., Bertolami, M.C., Jackson, G., Strauss, B., Meier, B. JAMA (2002) [Pubmed]
  14. Rhabdomyolysis in fatal arsenic trioxide poisoning. Sanz, P., Corbella, J., Nogué, S., Munné, P., Rodriguez-Pazos, M. JAMA (1989) [Pubmed]
  15. Rhabdomyolysis and renal injury with lovastatin use. Report of two cases in cardiac transplant recipients. Corpier, C.L., Jones, P.H., Suki, W.N., Lederer, E.D., Quinones, M.A., Schmidt, S.W., Young, J.B. JAMA (1988) [Pubmed]
  16. Acute rhabdomyolysis associated with cocaine intoxication. Roth, D., Alarcón, F.J., Fernandez, J.A., Preston, R.A., Bourgoignie, J.J. N. Engl. J. Med. (1988) [Pubmed]
  17. Treatment of cardiomyopathy and rhabdomyolysis in long-chain fat oxidation disorders using an anaplerotic odd-chain triglyceride. Roe, C.R., Sweetman, L., Roe, D.S., David, F., Brunengraber, H. J. Clin. Invest. (2002) [Pubmed]
  18. Rhabdomyolysis after theophylline overdose. Rumpf, K.W., Wagner, H., Criee, C.P., Schwarck, H., Klein, H., Kreuzer, H., Scheler, F. Lancet (1985) [Pubmed]
  19. Rhabdomyolysis and paraneoplastic stiff-man syndrome with amphiphysin autoimmunity. Petzold, G.C., Marcucci, M., Butler, M.H., van Landeghem, F.K., Einhäupl, K.M., Solimena, M., Valdueza, J.M., De Camilli, P. Ann. Neurol. (2004) [Pubmed]
  20. Safety considerations for statins. Bolego, C., Baetta, R., Bellosta, S., Corsini, A., Paoletti, R. Curr. Opin. Lipidol. (2002) [Pubmed]
  21. A causative role for redox cycling of myoglobin and its inhibition by alkalinization in the pathogenesis and treatment of rhabdomyolysis-induced renal failure. Moore, K.P., Holt, S.G., Patel, R.P., Svistunenko, D.A., Zackert, W., Goodier, D., Reeder, B.J., Clozel, M., Anand, R., Cooper, C.E., Morrow, J.D., Wilson, M.T., Darley-Usmar, V., Roberts, L.J. J. Biol. Chem. (1998) [Pubmed]
  22. Clinical pharmacokinetics of atorvastatin. Lennernäs, H. Clinical pharmacokinetics. (2003) [Pubmed]
  23. Elimination kinetics of myoglobin and creatine kinase in rhabdomyolysis: implications for follow-up. Lappalainen, H., Tiula, E., Uotila, L., Mänttäri, M. Crit. Care Med. (2002) [Pubmed]
  24. A novel mitochondrial tRNA phenylalanine mutation presenting with acute rhabdomyolysis. Chinnery, P.F., Johnson, M.A., Taylor, R.W., Lightowlers, R.N., Turnbull, D.M. Ann. Neurol. (1997) [Pubmed]
  25. Prevalence and predictors of rhabdomyolysis in patients with hypophosphatemia. Singhal, P.C., Kumar, A., Desroches, L., Gibbons, N., Mattana, J. Am. J. Med. (1992) [Pubmed]
  26. HMG CoA reductase inhibitor-induced myotoxicity: pravastatin and lovastatin inhibit the geranylgeranylation of low-molecular-weight proteins in neonatal rat muscle cell culture. Flint, O.P., Masters, B.A., Gregg, R.E., Durham, S.K. Toxicol. Appl. Pharmacol. (1997) [Pubmed]
  27. Chest wall pain and possible rhabdomyolysis after chloropicrin exposure. A case series. Prudhomme, J.C., Bhatia, R., Nutik, J.M., Shusterman, D.J. J. Occup. Environ. Med. (1999) [Pubmed]
  28. Morphological effects in the mouse myocardium after methylenedioxymethamphetamine administration combined with loud noise exposure. Gesi, M., Lenzi, P., Soldani, P., Ferrucci, M., Giusiani, A., Fornai, F., Paparelli, A. Anat. Rec. (2002) [Pubmed]
  29. Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors. Williams, D., Feely, J. Clinical pharmacokinetics. (2002) [Pubmed]
  30. A frameshift variant of CYP2C8 was identified in a patient who suffered from rhabdomyolysis after administration of cerivastatin. Ishikawa, C., Ozaki, H., Nakajima, T., Ishii, T., Kanai, S., Anjo, S., Shirai, K., Inoue, I. J. Hum. Genet. (2004) [Pubmed]
  31. Heme oxygenase activity and some indices of antioxidant protection in rat liver and kidney in glycerol model of rhabdomyolysis. Kaliman, P.A., Strel'chenko, E.V., Nikitchenko, I.V., Filimonenko, V.P. Bull. Exp. Biol. Med. (2003) [Pubmed]
  32. Serum concentrations of collagen degrading enzymes and their inhibitors after downhill running. Koskinen, S.O., Höyhtyä, M., Turpeenniemi-Hujanen, T., Martikkala, V., Mäkinen, T.T., Oksa, J., Rintamäki, H., Löfberg, M., Somer, H., Takala, T.E. Scandinavian journal of medicine & science in sports. (2001) [Pubmed]
  33. Rhabdomyolysis: an evaluation of 475 hospitalized patients. Melli, G., Chaudhry, V., Cornblath, D.R. Medicine (Baltimore) (2005) [Pubmed]
  34. Enteral feeding improves outcome and protects against glycerol-induced acute renal failure in the rat. Roberts, P.R., Black, K.W., Zaloga, G.P. Am. J. Respir. Crit. Care Med. (1997) [Pubmed]
  35. Accumulation of lovastatin, but not pravastatin, in the blood of cyclosporine-treated kidney graft patients after multiple doses. Olbricht, C., Wanner, C., Eisenhauer, T., Kliem, V., Doll, R., Boddaert, M., O'Grady, P., Krekler, M., Mangold, B., Christians, U. Clin. Pharmacol. Ther. (1997) [Pubmed]
  36. Parenchymal versus reticuloendothelial iron overload in the liver: distinction with MR imaging. Siegelman, E.S., Mitchell, D.G., Rubin, R., Hann, H.W., Kaplan, K.R., Steiner, R.M., Rao, V.M., Schuster, S.J., Burk, D.L., Rifkin, M.D. Radiology. (1991) [Pubmed]
  37. PCP, physical restraint, and rhabdomyolysis. Lahmeyer, H.H. The Journal of clinical psychiatry. (1983) [Pubmed]
 
WikiGenes - Universities